View in EDS HTML Full Text PDF Full Text

Pharmacometabolomics applied to low‐dose interleukin‐2 treatment in amyotrophic lateral sclerosis.

Saved in:
Bibliographic Details
Title: Pharmacometabolomics applied to low‐dose interleukin‐2 treatment in amyotrophic lateral sclerosis.
Authors: Alarcan, Hugo1,2 (AUTHOR), Bruno, Clément3 (AUTHOR), Emond, Patrick2,4 (AUTHOR), Raoul, Cédric5,6 (AUTHOR), Vourc'h, Patrick1,2 (AUTHOR), Corcia, Philippe2,7 (AUTHOR), Camu, William5,6 (AUTHOR), Veyrune, Jean‐Luc8 (AUTHOR), Garlanda, Cecilia9,10 (AUTHOR), Locati, Massimo10 (AUTHOR), Juntas‐Morales, Raúl11 (AUTHOR), Saker, Safaa12 (AUTHOR), Suehs, Carey13 (AUTHOR), Masseguin, Christophe14 (AUTHOR), Kirby, Janine15 (AUTHOR), Shaw, Pamela15 (AUTHOR), Malaspina, Andrea16 (AUTHOR), De Vos, John17 (AUTHOR), Al‐Chalabi, Ammar18 (AUTHOR), Leigh, P. Nigel19 (AUTHOR)
Source: Annals of the New York Academy of Sciences. Jun2024, Vol. 1536 Issue 1, p82-91. 10p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:00778923
DOI:10.1111/nyas.15147